PATENT CLAIM ANALYSIS

Application Number: 15924250
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "381000"]

Abstract:
Novel crystalline forms of trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl) propionate-(S)-3′-methyl-2′-(pentanoyl{2″-(tetrazol-5-ylate)biphenyl-4′-ylmethyl}amino)butyrate] hydrate, methods for their preparation, pharmaceutical compositions comprising these new forms, and use of them for treating or delaying progression or onset of diseases or disorders related to activity of angiotensin receptor 1 (AT1) blockage and neprilysin (NEP) inhibition, such as heart failure, are disclosed.

Claim (Index 4):
The crystalline Form II of  claim 2 , wherein the X-ray powder diffraction pattern further comprising the following 2\u03b8 values measured using CuK\u03b1 radiation: 5.5\u00b0\u00b10.2\u00b0, 5.8\u00b0\u00b10.2\u00b0, 18.5\u00b0\u00b10.2\u00b0 and 20.1\u00b0\u00b10.2\u00b0.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 1.3871
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15528153', '15764244', '11722360', '14311788', '15568550']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7650904623824515
- 35 USC 102 Novelty (BERT): 0.6354577133079209
- Combined Prediction Score: 0.7521271874749984
- Mean Citation Score: 363.97922
- Max Citation Score: 613.86475
- Similarity Product: 557.3955548357069

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test